Apogee Therapeutics, Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$79.24(as of Mar 23, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Apogee Therapeutics, Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$79.24
Ticker SymbolAPGE
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees261
CountyUSA
Market Cap$4,546.7M
EBIDTA-284.2M
10-Day Moving Average71.70
P/E Ratio-18.80
20-Day Moving Average71.44
Forward P/E Ratio0.00
50-Day Moving Average71.43
Earnings per Share-4.22
200-Day Moving Average55.75
Profit Margin-Infinity%
RSI62.64
Shares Outstanding55.4M
ATR4.73
52-Week High84.56
Volume3,451,894
52-Week Low26.20
Most Recent Support Level65.22
Book Value903.9M
Most Recent Resistance Level76.27
P/B Ratio5.32
Upper Keltner82.08
P/S RatioInfinity
Lower Keltner60.80
Debt-to-Equity Ratio82.08
Next Earnings DateUnknown
Cash Surplus103.6M
Next Ex-Dividend DateUnknown

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops Zumilokibart (APG777), a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of atopic dermatitis, which is in phase 2 clinical trials; and for the treatment of asthma and eosinophilic esophagitis which is in phase 1 clinical trial. It also develops APG279 which is in phase 1 clinical trial for the treatment of atopic dermatitis; APG273 which is in phase 1 clinical trial for the treatment of asthma and chronic obstructive pulmonary disease; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Apogee Therapeutics, Inc. Common Stock In Our Stock Scanner

As of Mar 24, 2026
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.